Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis.

Anti-cyclic citrullinated Peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis.

OBJECTIVE: Patients with rheumatoid arthritis (RA) are at risk to develop RA-associated interstitial lung disease (RA-ILD). This retrospective study aimed to investigate the potential association of the positivity of serum anti-cyclic citrullinated peptide antibody (anti-CCP2) and rheumatoid factor...

Full description

Bibliographic Details
Main Authors: Yufeng Yin, Di Liang, Lidan Zhao, Yang Li, Wei Liu, Yan Ren, Yongzhe Li, Xiaofeng Zeng, Fengchun Zhang, Fulin Tang, Guangliang Shan, Xuan Zhang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3990563?pdf=render

Internet

http://europepmc.org/articles/PMC3990563?pdf=render

Similar Items